MedTrace Logo

Treatment of Androgenetic Alopecia in Males and Females

NCT01437163 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2016-07-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of Low Level Laser and Light Therapy system configured in a novel product called the TopHat 655 system, for promoting hair growth in males and females diagnosed with androgenetic alopecia of the head.

Conditions

Interventions

DEVICE

TopHat 655 rejuvenation system

TopHat 655 system is to be applied every other day for 16 weeks for a pre-programmed time period

DEVICE

Laser and/or Light Hair Rejuvenation System

A red incandescent light source replaces all lasers and light emitting diodes.

Sponsors & Collaborators

  • Apira Science, Inc.

    lead INDUSTRY

Principal Investigators

  • Raymond J. Lanzafame, MD · Raymond J. Lanzafame, MD

  • Peter S. Halperin, MD · Peter S. Halperin, MD

  • Adolfo Fernandez-Obregon, MD · Adolfo Fernandez-Obregon, MD

  • Jeffrey A Sklar, MD · Center for Aesthetic Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01437163 on ClinicalTrials.gov